Scholars Central

Review articlePublished 31 Aug 2022

Biopharmaceutical Manufacturing Process Validation and Quality Risk Management

Authors: Raghu Tadagavadi

Department of Medicine, Penn State University College of Medicine, USA

Clinical Pharmacology & Biopharmaceutics

Volume 11 · Issue 8 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Manufacturing processes for biopharmaceuticals must be designed to produce products that have harmonious quality attributes. This entails removing contaminations and pollutants that include endotoxins, contagions, cell membranes, nucleic acids, proteins, culture media factors, process chemicals, and ligands percolated from chromatography media, as well as product variations, summations, and inactive forms. Manufacturing processes should be validated by applying a scientifically rigorous and well- proved exercise demonstrating that the process, and every piece of outfit used in it, constantly performs as intended, and that the process, when operated within established limits, generates a product that routinely and reliably meets its required quality norms.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Raghu Tadagavadi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels